Business Description
Median Technologies
ISIN : FR0011049824
Total Employee Number:
134Compare
Compare
Traded in other countries / regions
ALMDT.France4ZG.Germany IPO Date
2011-05-20Description
Median Technologies is engaged in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development. The company focuses on the oncology clinical trials market and the cancer patient care market. The company has two platforms, iSee for imaging services in clinical trials and eyonis for non-invasive diagnostic tests based on imaging for the treatment of patients suffering from cancer. Its revenue is generated from contracts for providing imaging services for oncology clinical trials using dedicated software. Geographically, the company generates revenue from EMEA, the USA/Canada, and China.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.85 | |||||
Equity-to-Asset | -0.98 | |||||
Debt-to-Equity | -0.62 | |||||
Debt-to-EBITDA | -0.87 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -1.88 | |||||
Beneish M-Score | -4.7 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -24.9 | |||||
3-Year EBITDA Growth Rate | 15.1 | |||||
3-Year EPS without NRI Growth Rate | 23.2 | |||||
3-Year FCF Growth Rate | 23.1 | |||||
3-Year Book Growth Rate | -27.7 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 27.87 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 9.69 | |||||
9-Day RSI | 22.48 | |||||
14-Day RSI | 30.87 | |||||
3-1 Month Momentum % | 5.86 | |||||
6-1 Month Momentum % | 21.16 | |||||
12-1 Month Momentum % | 147.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.67 | |||||
Quick Ratio | 0.67 | |||||
Cash Ratio | 0.39 | |||||
Days Sales Outstanding | 100.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -32.5 | |||||
Shareholder Yield % | -12.36 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 102.98 | |||||
Operating Margin % | -68.24 | |||||
Net Margin % | -145.85 | |||||
EBITDA Margin % | -107.59 | |||||
FCF Margin % | -77.8 | |||||
OCF Margin % | -74.6 | |||||
ROA % | -128.16 | |||||
ROIC % | -36.63 | |||||
3-Year ROIIC % | 30.89 | |||||
ROC (Joel Greenblatt) % | -1410.78 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 5.87 | |||||
EV-to-EBIT | -7.24 | |||||
EV-to-EBITDA | -8.15 | |||||
EV-to-Revenue | 8.76 | |||||
EV-to-FCF | -12.65 | |||||
Price-to-GF-Value | 2.38 | |||||
Price-to-Median-PS-Value | 0.98 | |||||
Earnings Yield (Greenblatt) % | -13.82 | |||||
FCF Yield % | -9.03 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Median Technologies Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 23.359 | ||
| EPS (TTM) (€) | -1.148 | ||
| Beta | 1.3353 | ||
| 3-Year Sharpe Ratio | 0.23 | ||
| 3-Year Sortino Ratio | 0.44 | ||
| Volatility % | 79.72 | ||
| 14-Day RSI | 30.87 | ||
| 14-Day ATR (€) | 0.24982 | ||
| 20-Day SMA (€) | 4.63075 | ||
| 12-1 Month Momentum % | 147.17 | ||
| 52-Week Range (€) | 1.68 - 7.27 | ||
| Shares Outstanding (Mil) | 48.97 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Median Technologies Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Median Technologies Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Median Technologies Frequently Asked Questions
What is Median Technologies(XPAR:ALMDT)'s stock price today?
The current price of XPAR:ALMDT is €4.11. The 52 week high of XPAR:ALMDT is €7.27 and 52 week low is €1.68.
When is next earnings date of Median Technologies(XPAR:ALMDT)?
The next earnings date of Median Technologies(XPAR:ALMDT) is .
Does Median Technologies(XPAR:ALMDT) pay dividends? If so, how much?
Median Technologies(XPAR:ALMDT) does not pay dividend.
Press Release
| Subject | Date | ||
|---|---|---|---|
| AG Mednet and Median Technologies Partnership Supports Global Clinical Trials Portfolio, Including Extensive Programs in China | 2019-07-08 |
Articles on Median Technologies
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers